Abstract
Objective:
Data suggest that female obesity impairs uterine receptivity and increases the risk of fetal and neonatal mortality. We analyzed the reproductive outcomes of gestational carriers (GCs) undergoing donated oocytes and assisted reproductive technology according to body mass index (BMI).
Design:
A retrospective analysis of 163 GCs undergoing 226 in vitro fertilization (IVF) and embryo transfer cycles.
Methods:
GCs undergoing in vitro fertilization and embryo transfer cycles were analyzed and divided according to their BMI (healthy weight: 20−24.9 kg m–2 (n=77 in 114 cycles); overweight: 25−29.9 kg m–2 (n=55 in 71 cycles); and obese: 30−35 kg m–2 (n=31 in 41 cycles)). All GCs underwent a complete medical evaluation and were cleared for pregnancy before being selected. Overweight and obese GCs also underwent a metabolic screening, including an oral glucose tolerance test and lipid profile. The main outcomes measured were clinical pregnancy and live birth rates, antenatal and neonatal outcomes.
Results:
Clinical pregnancy and live birth rates were similar despite increasing BMI. There were no statistically significant differences in the implantation rates, clinical pregnancy rates or live birth rates per embryo transfer among patients in the three BMI groups. In the healthy weight, overweight and obese GCs, the clinical pregnancy rates per GC were 72%, 84% and 79%, and per embryo transfer rates were 52%, 49% and 56%, respectively; P=NS. The live birth rates per GC were 70%, 84% and 75%, and per embryo transfer rates were 50%, 49% and 53%, respectively; P=NS. Twin rates were similar between the groups (35%, 31% and 29%, respectively; P=NS). There were no differences in gestational diabetes, preterm admissions or cesarean section rates. Neonatal intensive care unit admissions were similar (11%, 13% and 12%, respectively; P=NS), and no maternal, neonatal or infant mortality occurred.
Conclusions:
These data show that increasing obesity does not impair the reproductive outcome in GC cycles. Larger sample size is indicated to verify these findings. Furthermore, this study suggests that the standard metabolic screening used for GCs may lead to selection of healthier patients compared with women of comparable BMI who conceive outside of a fertility clinic setting, indicating the metabolic profile, rather than BMI, may better explain differences in pregnancy outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization. Obesity and Overweight Fact Sheet No. 311. Updated January 2015. Available at http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed April 2015).
Suresh A, Liu A, Poulton A, Quinton A, Amer Z, Mongelli M et al. Comparison of maternal abdominal subcutaneous fat thickness and body mass index as markers for pregnancy outcomes: a stratified cohort study. Aust N Z J Obstet Gynaecol 2012; 52: 420–426.
Stein C, Colditz GA . The epidemic of obesity. J Clin Endocrinol Metab 2004; 89: 2522–2525.
Harlass FE, Plymate SR, Fariss BL, Belts RP . Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril 1984; 42: 649–652.
Hollmann M, Runnebaum B, Gerhard I . Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod 1996; 11: 1884–1891.
Liat S, Cabero L, Hod M, Yogev Y . Obesity in obstetrics. Best Pract Res Clin Obstet Gynaecol 2015; 2979–2990.
McDonald SD, Han Z, Mulla S, Beyene J Knowledge Synthesis Group. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010; 341: c3438.
Aune D, Saugstad OD, Henriksen T, Tonstad S . Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA 2014; 311: 1536–1546.
Brewer CJ, Balen AH . The adverse effects of obesity on conception and implantation. Reproduction 2010; 140: 347–364.
Santangeli L, Sattar N, Huda S . Impact of maternal obesity on perinatal and childhood outcomes. Best Pract Res Clin Obstet Gynaecol 2015; 29: 438–448.
Lashen H, Fear K, Sturdee DW . Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case–control study. Hum Reprod 2004; 19: 1644–1646.
Centers for Disease Control and Prevention. Section 5: ART Trends 2002-2011. Available at http://www.cdc.gov/art/pdf/2012-report/national-summary/art_2012_national_summary_report.pdf (accessed 31 December 2014).
Centers for Disease Control and Prevention. Section 2: ART cycles using fresh, nondonor eggs or embryos (part C). Available at http://www.cdc.gov/art/pdf/2012-report/national-summary/art_2012_national_summary_report.pdf (accessed 31 December 2014).
Dar S, Lazer T, Swanson S, Silverman J, Wasser C, Moskovtsev SI et al. Assisted reproduction involving gestastional surrogacy: an analysis of the medical, psychosocial and legal issues: experience from a large surrogacy program. Hum Reprod 2015; 30: 345–352.
Anchan RM, Missmer SA, Correia KF, Ginsburg ES . Gestational carriers: a viable alternative for women with medical contraindications to pregnancy. Open J Obstet Gynecol 2013; 3: 24–31.
Practice Committee of ASRM and SART. Recommendations for practices utilizing gestational carriers: an ASRM Practice Committee guideline. Fertil Steril 2012; 97: 1301–1308.
Goldenberg R, Punthakee Z . Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2013; 37: S8–S11.
Bellver J, Busso C, Pellicer A, Remohi J, Simon C . Obesity and assisted reproductive technology outcomes. Reprod Biomed Online 2006; 12: 562–568.
Maheshwari A, Stofberg L, Bhattacharya S . Effect of overweight and obesity on assisted reproductive technology – a systematic review. Hum Reprod Update 2007; 13: 433–444.
Esinler I, Bozdag G, Yarali H . Impact of isolated obesity on ICSI outcome. Reprod Biomed Online 2008; 17: 583–587.
Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R, SART Writing Group. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod 2011; 26: 245–252.
Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 2003; 79: 1136–1140.
Cancello R, Clement K . Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006; 113: 1141–1147.
Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM . Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 2007; 166: 1312–1319.
Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC . A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility. Eur J Clin Nutr 2009; 63: 78–86.
Jovanovic L, Knopp RH, Kim H, Cefalu WT, Zhu X-D, Lee YJ et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy. Diabetes Care 2005; 28: 1113–1117.
Styne-Gross A, Elkind-Hirsch K, Scott RT . Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil Steril 2005; 83: 1629–1634.
Tamer Erel C, Senturk LM . The impact of body mass index on assisted reproduction. Curr Opin Obstet Gynecol 2009; 21: 228–235.
Hutley L, Prins JB . Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci 2005; 330: 280–289.
Karlsson C, Lindell K, Svensson E, Bergh C, Lind P, Billig H et al. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 1997; 82: 4144–4148.
Agarwal SK, Vogel K, Weitsman SR, Magoffin DA . Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 1999; 84: 1072–1076.
Llaneza-Suarez D, Llaneza P, González C, De-La-Fuente P, García-Ochoa C, Garrido P et al. Assessment of follicular fluid leptin levels and insulin resistance as outcome predictors in women undergoing in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril 2014; 102: 1619–1625.
Ethics Committee of the American Society of Reproductive Medicine. Consideration of the gestational carrier: a committee opinion. Fertil Steril 2013; 99: 1838–1841.
Acknowledgements
We thank the Center for Surrogate Parenting, Inc., and The Surrogacy Center, LLC, for their participation in data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare conflict of interest.
Rights and permissions
About this article
Cite this article
Coyne, K., Whigham, L., O'Leary, K. et al. Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity?. Int J Obes 40, 171–175 (2016). https://doi.org/10.1038/ijo.2015.159
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2015.159
This article is cited by
-
Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study
Journal of Assisted Reproduction and Genetics (2017)